---
$id: https://graph.org.ai/products/commodity/51372209
$type: Product
source: UNSPSC
code: "51372209"
title: "Dextropropoxyphene napsilate"
class: "51372200"
classTitle: "Controlled substance analgesic morpholines"
family: "51370000"
familyTitle: "Controlled substance analgesics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dextropropoxyphene napsilate

**UNSPSC Code**: 51372209
**Class**: [Controlled substance analgesic morpholines](Controlled substance analgesic morpholines.mdx)
**Family**: [Controlled substance analgesics](../Controlled substance analgesics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an opioid receptor agonist and opioid, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 38M219L1OJ. European Medicines Agency schedules Dextropropoxyphene napsilate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01650MIG. Dextropropoxyphene napsilate generally arises in the molecular formula C22H29NO2.C10H8O3S.H2O. The term 'dextropropoxyphene napsilate' is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule dextropropoxyphene napsilate under HS 29221400. SMILES: CCC(=O)O[C@](CC1CCCCC1)(C2CCCCC2)[C@H](C)CN(C)C.C1CCC2CC(CCC2C1)S(=O)(=O)O.O.

